42
Participants
Start Date
May 31, 2006
Primary Completion Date
August 31, 2007
Study Completion Date
March 31, 2011
Cetuximab
Cetuximab: an initial loading dose of 400 mg/m2 will be given followed by 250 mg/m2 administered weekly. Cetuximab will be given first followed by gemcitabine on the weeks the patient receives cytotoxic chemotherapy on day 1. Cetuximab will be given as a single agent on Day 8. The treatment will be given on two-week cycles.
Gemcitabine Hydrochloride
Gemcitabine 1000 mg/m2 IV day 1. The treatment will be given on two-week cycles.
Oxaliplatin
Oxaliplatin 100 mg/m2 IV day 2. The treatment will be given on two-week cycles.
University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami
University of Miami
OTHER